66 studies found for:    Open Studies | "Warfarin"
Show Display Options
Rank Status Study
21 Not yet recruiting Randomized Controlled Feasibility Trial of the Fearon Algorithm to Improve Management of Unstable Warfarin
Condition: Hypoprothrombinemia
Interventions: Other: Warfarin adjustment using the Fearon algorithm;   Other: Warfarin adjustment using standard dosing
22 Unknown  Evaluation of Maintenance Dosing vs Loading Dosing Upon Restarting Warfarin Therapy: A Prospective Randomized Trial
Condition: Anticoagulation
Interventions: Drug: warfarin;   Drug: Warfarin
23 Recruiting Phase I Study to Evaluate the Effect of LDE225 on the Pharmacokinetics of Bupropion and Warfarin in Patients
Condition: Advanced Solid Tumor
Interventions: Drug: LDE225;   Drug: Wafarin;   Drug: Bupropion
24 Unknown  The Safety of Cataract Removal by Phacoemulsification Surgery in Patients Under Anti-aggregant and Coumadin Treatment
Conditions: Efficacy;   Complications
Intervention: Procedure: cataract surgery with phacoemulsification
25 Unknown  Determinants of Warfarin Metabolism
Condition: Healthy
Interventions: Drug: Warfarin;   Drug: Phenytoin
26 Unknown  Genetic Determinants of Warfarin Anticoagulation Effect
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation
Intervention: Drug: Warfarin
27 Recruiting Genotype-guided Warfarin Individualized Treatment
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis
Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin;   Behavioral: Standard initiation dose for warfarin
28 Recruiting The Influence of Preoperative Warfarin Medication on Thromboelastography and Blood Transfusion
Condition: Atrial Fibrillation
Intervention:
29 Not yet recruiting A Clinical Study of Lyophilized Plasma in Patients on Warfarin
Condition: Anticoagulant Therapy
Interventions: Biological: Lyophilized Plasma;   Biological: Licensed Plasma
30 Recruiting Rivaroxaban Versus Warfarin in Acute Ischemic Stroke With Atrial Fibrillation
Conditions: Ischemic Stroke;   Transient Ischemic Attack
Interventions: Drug: Rivaroxaban;   Drug: Warfarin
31 Unknown  Pharmacogenetic Study of Warfarin Dose-Response: a Prospective Trial
Condition: Cardiovascular Diseases
Intervention:
32 Unknown  Relationship Between Folic Acid and Warfarin Metabolism and Effect
Condition: Folic Acid Deficiency
Intervention: Drug: Folic acid
33 Recruiting Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention: Drug: warfarin
34 Recruiting Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
Conditions: Atrial Fibrillation;   Coronary Artery Disease
Interventions: Drug: Ticagrelor+Warfarin;   Drug: Clopidogrel+Aspirin+Warfarin
35 Recruiting Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
Condition: Atrial Fibrillation
Intervention: Device: LAA closure system
36 Not yet recruiting Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy
Condition: Venous Thrombembolic Events.
Intervention: Drug: Dabigatran.
37 Not yet recruiting The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage
Condition: Atrial Fibrillation
Intervention:
38 Recruiting The Effect of BI 187004 on the Pharmacokinetics of Cytochrome P450 Substrates (Caffeine, Warfarin, Omeprazole, Metoprolol and Midazolam) and a P Glycoprotein Substrate (Digoxin)
Condition: Healthy
Interventions: Drug: midazolam;   Drug: caffeine;   Drug: digoxin;   Drug: warfarin;   Drug: omeprazole;   Drug: BI 187004;   Drug: metoprolol
39 Recruiting Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)
Conditions: Atrial Fibrillation;   Percutaneous Coronary Intervention
Interventions: Drug: Dabigatran Etexilate 110mg;   Drug: Warfarin 3mg;   Drug: Aspirin;   Drug: Dabigatran Etexilate 150mg;   Drug: Clopidogrel or Ticagrelor;   Drug: Warfarin 5mg;   Drug: Warfarin 1mg
40 Unknown  Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing
Conditions: Atrial Fibrillation;   Deep Venous Thrombosis;   Heart Valve Replacement;   Pulmonary Embolism
Intervention: Drug: Coumadin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years